We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300661:SZSESG Micro Corp. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥74.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

SG Micro Corp trades around 74 CNY, comfortably above its 20‑day (69.6), 50‑day (71.3) and 200‑day (72.4) simple moving averages, indicating short‑term price strength. The MACD is bullish (line = 0.95, signal = ‑0.14) and the RSI sits at a neutral 55.5, while volume is on an upward trend, supporting a near‑term hold stance. However, the stock’s valuation is extreme: a trailing PE of 82.2 dwarfs the semiconductor industry average of 34.4, and the discounted cash‑flow model suggests a fair value near 15.4 CNY, implying a massive upside‑downside gap. Despite a modest dividend yield of 0.21% and a low payout ratio (~17%), the company’s cash pile (~2.23 B CNY) far exceeds its debt (~0.16 B CNY), making the dividend sustainable but the price hard to justify. The sector’s inherent cyclicality, combined with a high 30‑day volatility of 63.5% and a negative beta (‑0.56), adds market‑risk pressure. Investor sentiment is at an “Extreme Greed” level (81.48 on the fear‑greed index), which may be inflating the current price beyond fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above short‑term moving averages
  • Increasing volume supporting momentum
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Severe overvaluation relative to peers and DCF
  • Strong cash position but limited free cash flow
  • Stable dividend with low payout ratio

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • PE far above industry norms and DCF fair value
  • Negative beta and high volatility indicating uncertain market dynamics
  • Cyclical semiconductor sector and regulatory environment in China

Key Metrics & Analysis

Financial Health

Revenue Growth13.10%
Profit Margin15.09%
P/E Ratio82.2
ROE11.85%
ROA3.43%
Debt/Equity3.22
P/B Ratio9.3
Op. Cash FlowCN¥450.3M
Free Cash FlowCN¥-152710240
Industry P/E34.4

Technical Analysis

TrendBearish
RSI55.5
SupportCN¥61.98
ResistanceCN¥79.98
MA 20CN¥69.62
MA 50CN¥71.29
MA 200CN¥72.40
MACDBullish
VolumeIncreasing
Fear & Greed Index81.48

Valuation

Fair ValueCN¥15.43
Target PriceCN¥88.13
Upside/Downside19.09%
GradeOvervalued
TypeBlend
Dividend Yield0.21%

Risk Assessment

Beta-0.56
Volatility63.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.